Xmark Opportunity Partners, LLC

Xmark Opportunity Partners, LLC has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Aeolus Pharmaceuticals, Inc. and Genaera Corp. We count 228 filings; the first trade dates from 6 June 2006 and the latest from 19 February 2013.

In open-market terms, that means 180 purchases worth €7.6M on one side and 3 sales worth €752k on the other. No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 share grants. Since January 2013: no purchases and 1 sale on the market.

Half of the purchases are above €8,937 and half below. After 74 purchases with a full 90-day history, the hit rate stands at 23% and the median 90-day move at -9.1%. Past outcomes like these are no guarantee of what comes next.

Most recently, on 21 February 2013, the filings show an open-market sale worth €444k in Aeolus Pharmaceuticals, Inc. The clock since the last published purchase (16 August 2010) now reads 5,913 days. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.